K. Squires

Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study

Frank van Leth, Praphan Phanuphak, Kiat Ruxrungtham et al. · The Lancet · 2004 · 683 citations

Treatment And Prevention, Medicine, First-line Antiretroviral Therapy +9

Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor

Jon H. Condra, Daniel Holder, William A. Schleif et al. · Journal of Virology · 1996 · 405 citations · Full text

Immunology, Vivo Viral Resistance, Molecular Biology +17

Experimental visceral leishmaniasis: role of endogenous IFN-gamma in host defense and tissue granulomatous response.

K. Squires, Robert D. Schreiber, M J McElrath et al. · The Journal of Immunology · 1989 · 171 citations

Immunology, Pathology, Immunologic Mechanism +19

Phase I/II study of the pharmacokinetics, safety and antiretroviral activity of tenofovir alafenamide, a new prodrug of the HIV reverse transcriptase inhibitor tenofovir, in HIV-infected adults

Martin Markowitz, Andrew Zolopa, K. Squires et al. · Journal of Antimicrobial Chemotherapy · 2014 · 127 citations · Full text

New Prodrug, Tenofovir Alafenamide Group, Phase I/ii Study +15

Acquired resistance and granuloma formation in experimental visceral leishmaniasis. Differential T cell and lymphokine roles in initial versus established immunity

Henry W. Murray, K. Squires, C D Miralles et al. · The Journal of Immunology · 1992 · 116 citations